| Mrs Melanie Sue Gonnering, OTR/L | |
|
200 S 9th St, De Pere, WI 54115-1393 | |
| (920) 338-4146 | |
| Not Available |
| Full Name | Mrs Melanie Sue Gonnering |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 200 S 9th St, De Pere, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104299494 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 5550 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Melanie Sue Gonnering, OTR/L W2151 Lau Road, Kaukauna, WI 54130 Ph: (920) 788-6758 | Mrs Melanie Sue Gonnering, OTR/L 200 S 9th St, De Pere, WI 54115-1393 Ph: (920) 338-4146 |
News Archive
Inhibikase Therapeutics, a specialty pharmaceutical company based in Atlanta, Georgia, will discuss simultaneous antiviral and antibacterial activity from small molecule agents at the 2009 BIOCOM Investor Conference. Employing a host-factor targeted approach, Inhibikase will illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases in humans.
In Sweden, care for bipolar disorder shows inequalities. They are associated both with socioeconomic factors and with gender, according to research from the University of Gothenburg. For instance, lithium — the treatment deemed to have the most stabilizing effect on the disorder — is administered to men more often than to women.
Pharmacyclics, Inc. today announced longer-term data from a Phase II investigator-initiated study showing Waldenstrom's macroglobulinemia (WM) patients treated with IMBRUVICA (ibrutinib) experienced sustained disease control with an overall response rate (ORR) of 91% after a median of 19.1 months of treatment and a 2-year overall survival (OS) rate of 95%.
BioTuesday Publishing Corporation, a division of Kilmer Lucas Inc., announced today its launch of an independent business and investing news blog, BioTuesday.ca, that will focus on exciting companies and technologies in the Canadian healthcare sector.
Hospi Corporation, a privately-held medical device company focused on nurse invented products that optimize patient care, today announced receipt of 510(k) clearance from the U.S. Food and Drug Administration for its first product, the Macy Catheter. The Macy Catheter is the only device designed and approved solely for ongoing rectal delivery of medications and liquids.
› Verified 6 days ago
Kathleen Phelps, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1142 Orlando Dr, De Pere, WI 54115 Phone: 920-339-0700 Fax: 920-330-0278 | |
Molly Kafka, OTD Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1142 Orlando Dr, De Pere, WI 54115 Phone: 920-339-0700 | |
Maggie M Larson, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1601 Lawrence Dr Ste 100, De Pere, WI 54115 Phone: 920-496-4700 | |
Carol Klak, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1142 Orlando Dr, De Pere, WI 54115 Phone: 920-339-0700 Fax: 920-330-0278 | |
Alexandria Horn, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 S 9th St, De Pere, WI 54115 Phone: 920-336-5680 | |
Ellen Katherine Lemay, COTA Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 200 S 9th St, De Pere, WI 54115 Phone: 920-338-4145 |